Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial
Clinical trial NCT03038256 · UNKNOWN
Trial details
- NCT number
- NCT03038256
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-31
- Primary completion
- 2023-04-01
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.